NASDAQ:ARPO
Delisted
Aerpio Pharmaceuticals Inc. Stock News
$13.14
-0.370 (-2.74%)
At Close: Aug 17, 2022
Aerpio (ARPO) Seeks Strategic Options for Pipeline Programs
10:32am, Wednesday, 06'th Jan 2021
Aerpio (ARPO) unveils strategic alternatives after it announced top-line results from a phase II study of razuprotafib in glaucoma patients in December.
Aerpio Pharmaceuticals (ARPO) Sees Hammer Chart Pattern: Time to Buy?
10:32am, Wednesday, 06'th Jan 2021
Aerpio Pharmaceuticals (ARPO) has been struggling lately, but the selling pressure may be coming to an end soon.
Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial
04:01pm, Tuesday, 05'th Jan 2021
CINCINNATI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio” or the “Company”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate
5 Biopharma Stocks Making Big Moves Monday
11:33am, Monday, 14'th Dec 2020
Even as the broader market trades higher in reaction to the availability of the first coronavirus vaccine under emergency use authorization, a slew of biopharma stocks are moving on company-specific u
Aerpio Announces Statistically Significant Topline Results from Razuprotafib Glaucoma Phase 2 Trial
05:00pm, Friday, 11'th Dec 2020
Primary endpoint achieved with twice-daily dose group at 28 day time point versus latanoprost control group.
Aerpio Pharmaceuticals, Inc. (ARPO) Management on Q3 2020 Results - Earnings Call Transcript
12:01pm, Tuesday, 10'th Nov 2020
Aerpio Pharmaceuticals, Inc. (ARPO) Management on Q3 2020 Results - Earnings Call Transcript
Aerpio Reports Third Quarter 2020 Financial Results and Provides Business Update
08:00am, Tuesday, 10'th Nov 2020
Conference Call Today, November 10 , 2020 at 8:30 a.m. EST
Aerpio Hosting Key Opinion Leader Call on New Therapeutic Agents for COVID-19
04:01pm, Thursday, 05'th Nov 2020
Call Taking Place on Thursday, November 12th @ 11amET Call Taking Place on Thursday, November 12th @ 11amET
Here's Why We're Not Too Worried About Aerpio Pharmaceuticals' (NASDAQ:ARPO) Cash Burn Situation
03:06pm, Monday, 17'th Aug 2020
Just because a business does not make any money, does not mean that the stock will go down. Indeed, Aerpio...
Aerpio Reports Second Quarter 2020 Financial Results and Provides Business Update
12:00pm, Wednesday, 12'th Aug 2020
* Initiated a Phase 2 Open Angle Glaucoma Trial; Recruiting Ahead of Schedule * Announced Partnership with I-SPY to Participate in a Clinical Trial to Treat ARDS in COVID-19 Patients * Announced a S
Gossamer Bio Announces Second Quarter 2020 Financial Results and Provides Corporate Update
12:00am, Tuesday, 11'th Aug 2020
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therap
Aerpio Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 12
12:00pm, Monday, 10'th Aug 2020
CINCINNATI, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
11:35am, Wednesday, 05'th Aug 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) * ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination with an oxygen machine to
CINCINNATI, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO) and The U.S. Government operating through the Medical Technology Enterprise Consortium (MTEC) a
